New guidelines for bipolar disorders

World Journal of Biological Psychiatry

Volumn 10, Issue 2, 2009, Pages 82-84

  Vieta, Eduard ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIPOLAR DISORDER; EDITORIAL; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; TREATMENT PLANNING; CLASSIFICATION; DRUG COMBINATION; EVIDENCE BASED MEDICINE;

NEUROLEPTIC AGENT; TRANQUILIZER;

ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 67650107014     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970902840131     Document Type: Editorial

References (37)

1. American Psychiatric Association. 2002. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159:1-50.
2. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder, third edition. Am J Psychiatry, in press.
3. Bauer M, Beaulieu S, Dunner DL, Lafer B, Kupka R. 2008. Rapid cycling bipolar disorder-diagnostic concepts. Bipolar Disord 10:153-162.
4. Calabrese JR, Kasper S, Johnson G, Tajima O, Vieta E, Yatham LN, et al. 2004. International Consensus Group on Bipolar I Depression Treatment Guidelines. J Clin Psychiatry 65: 571-579.
5. Cassidy F, Yatham LN, Berk M, Grof P. 2008. Pure and mixed manic subtypes: a review of diagnostic classification and validation. Bipolar Disord 10:131-143.
6. Colom F, Vieta E. The road to DSM-V: Bipolar disorder episode and course specifiers. Psychopathology, in press.
7. Dennehy EB, Suppes T, Rush AJ, Miller AL, Trivedi MH, Yatham LN, et al. 2005. Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project. Psychol Med 35:1695-1706.
8. First MB, Pincus HA, Schoenbaum M. 2009. Issues for DSM-V: Adding problem codes to facilitate assessment of quality of care. Am J Psychiatry 166:11-13.
9. Fountoulakis KN, Vieta E, Sanchez-Moreno J, Kaprinis SG, Goikolea JM, Kaprinis GS. 2005. Treatment guidelines for bipolar disorder: a critical review. J Affect Disord 86:1-10. (Pubitemid 40487954)
10. Ghaemi SN, Bauer M, Cassidy F, Malhi GS, Mitchell P, Phelps J, et al. 2008. ISBD Diagnostic Guidelines Task Force. Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report. Bipolar Disord 10:117-128.
11. Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, et al. 2008. ECNP consensus meeting. Bipolar depression. Nice, March 2007. Eur Neuropsychopharmacol 18:535-549.
12. Goodwin GM; Consensus Group of the British Association for Psychopharmacology. 2003. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 17:149-173.
13. Grunze H, Kasper S, Goodwin G, Bowden C, Moller HJ, Task Force on Treatment Guidelines for Bipolar Disorders. WFSBP. 2004. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry 5:120-135.
14. Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht RW, et al. 2002. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry 3:115-124.
15. Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht RW, et al. 2003. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry 4:5-13.
16. Grunze H, Vieta E, Goodwin G, Bowden C, Licht RW, Moller HJ, et al. 2009a. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the treatment of acute mania. World J Biol Psychiatry 10:85-116.
17. Grunze H, Vieta E, Goodwin G, Bowden C, Licht RW, Moller HJ, et al. 2009b. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the treatment of bipolar depression. World J Biol Psychiatry 10:85-116.
18. Grunze H, Vieta E, Goodwin G, Bowden C, Licht RW, Moller HJ, et al. 2009c. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on maintenance treatment. World J Biol Psychiatry 10:85-116.
19. Kasper S, Calabrese JR, Johnson G, Tajima O, Vieta E, Viguera A, et al. 2008. International Consensus Group on the Evidence-based Pharmacological Treatment of Bipolar I and II Depression. J Clin Psychiatry 69:1632-1646.
20. Klein DN. 2008. Classification of depressive disorders in the DSM-V: proposal for a two-dimension system. J Abnorm Psychol 117:552-560.
21. Kupfer DJ, Regier DA, Kuhl EA. 2008. On the road to DSM-V and ICD-11. Eur Arch Psychiatry Clin Neurosci 258 (Suppl 5):2-6.
22. Malhi GS, Green M, Fagiolini A, Peselow ED, Kumari V 2008. Schizoaffective disorder: diagnostic issues and future recommendations. Bipolar Disord 10:215-230.
23. Mitchell PB, Goodwin GM, Johnson GF, Hirschfeld RM. 2008. Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disord 10:144-152.
24. Moller HJ. 2008. The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):7-17
25. National Institute for Health and Clinical Excellence. 2006. Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. NICE Clinical Guideline 38.
26. Perlis RH. 2007. Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians. Curr Med Res Opin 23:467-475
27. Phelps J, Angst J, Katzow J, Sadler J. 2008. Validity and utility of bipolar spectrum models. Bipolar Disord 10:179-193.
28. Phillips ML, Frank E. 2006. Redefining bipolar disorder: toward DSM-V. Am J Psychiatry 163:1135-1136.
29. Phillips ML, Vieta E. 2007. Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V. Schizophr Bull 33:893-904.
30. Pies RW. Depression and the pitfalls of causality: Implications for DSM-V. J Affect Disord, in press.
31. Suppes T, Dennehy EB, Hirschfeld RM, et al. 2005. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 66:870-886.
32. Vieta E, Phillips ML. 2007. Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-Vand ICD-11. Schizophr Bull 33:886-892.
33. Vieta E, Suppes T 2008. Bipolar II disorder: arguments for and against a distinct diagnostic entity. Bipolar Disord 10:163-178.
34. Vieta E. 2008. Overcoming the current approach in bipolar disorder research: towards DSM-V and beyond. J Psychophar-macol 22:406-407
35. Yatham LN, Kennedy SH, O'Donovan C, et al. 2006. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord 8:721-739.
36. Yatham LN, Kennedy SH, Schaffer A, et al. 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) Collaborative Update of CANMAT Guidelines for the Management of Patients with Bipolar Disorder: Update 2009. Bipolar Disord, in press.
37. Youngstrom EA, Birmaher B, Findling RL. 2008. Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis. Bipolar Disord 10:194-214.